EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

MXene/PEDOT:PSS-based dual-biomarker impedimetric immunosensor for accurate differentiation of prostate cancer from BPH through urinary detection

Song Feng, Rashid Khan, Seongeun Lee, Seon Joon Kim, Taesung Kim, Yi Jae Lee

Biosensors and Bioelectronics · 2025-12 · 289 · 117888

DOI: 10.1016/j.bios.2025.117888 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biosensors and Bioelectronics, 2025-12. Verfasst von Song Feng und 5 weiteren Autor:innen. Beteiligte Einrichtung: Brain Science Institute, Korea Institute of Science and Technology (KIST), Seoul, Republic of Korea; School of Mechanical Engineering, Sungkyunkwan U…. Hauptthemen laut MEDLINE: Biosensing Techniques, Prostatic Neoplasms, Prostate-Specific Antigen, Prostatic Hyperplasia. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Korea Ministry of Trade Industry and Energy, Korea Institute of Science and Technology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Prostate cancer (PCa) is the second most common cancer among men worldwide. Although prostate-specific antigen (PSA) is widely used for PCa screening, it lacks specificity for distinguishing PCa from benign prostatic hyperplasia (BPH). β-2-microglobulin (β2m) is a sensitive biomarker for malignant tumors and can complement the PSA for improved diagnostic accuracy. In this study, a non-invasive dual-biomarker electrochemical immunosensor was developed for urinary detection of PSA and β2m. A gold electrode was modified with MXene deposition and PEDOT:PSS electropolymerized on MXene, then functionalized with PSA and β2m antibodies. The composite MXene/PEDOT:PSS (MX/PP) electrode enabled sensitive detection through electrochemical impedance spectroscopy (EIS), which achieved detection limits of 4.96 × 10-5 ng/mL for PSA and 1.1 × 10-4 ng/mL for β2m. A wide linear range (approximately 0.01-600 ng/mL) was demonstrated for both the biomarkers in urine. The sensor exhibited high selectivity, reproducibility, stability, and effective differentiation between PCa and BPH. The MX/PP interface provided enhanced conductivity and surface area for antibody functionalization. This simple dual immunosensor offers a promising platform for the non-invasive, accurate, and early diagnosis of prostate cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Biosensing TechniquesProstatic NeoplasmsProstate-Specific AntigenProstatic Hyperplasiabeta 2-MicroglobulinBiomarkers, TumorHumansMaleDielectric SpectroscopyImmunoassayLimit of DetectionAntibodies, ImmobilizedGoldDiagnosis, DifferentialPolymersNitritesTransition Elements

Stichwörter der Autor:innen

ImpedimetricMXene/PEDOT:PSSNon-invasiveProstate cancer differentiationUrine

Substanzen

Prostate-Specific Antigenbeta 2-MicroglobulinBiomarkers, TumorAntibodies, ImmobilizedGoldB2M protein, humanPolymersMXeneNitritesTransition Elements

Autor:innen und Institutionen

  • Brain Science Institute, Korea Institute of Science and Technology (KIST), Seoul, Republic of Korea; School of Mechanical Engineering, Sungkyunkwan University (SKKU), Suwon-si, Kyeonggi-do, Republic of Korea.
  • Brain Science Institute, Korea Institute of Science and Technology (KIST), Seoul, Republic of Korea; Division of Bio-Medical Science & Technology, KIST School, University of Science & Technology (UST), Seoul, Republic o…
  • Extreme Materials Research Center, Korea Institute of Science and Technology(KIST), Seoul, Republic of Korea; Department of Materials Science and Engineering, Korea University, Seoul, Republic of Korea.
  • Extreme Materials Research Center, Korea Institute of Science and Technology(KIST), Seoul, Republic of Korea; Convergence Research Center for Solutions to Electromagnetic Interference in Future-mobility, Korea Institute…
  • School of Mechanical Engineering, Sungkyunkwan University (SKKU), Suwon-si, Kyeonggi-do, Republic of Korea.

Förderung

  • Korea Ministry of Trade Industry and Energy
  • Korea Institute of Science and Technology

Zitieren

APA

Feng, S., Khan, R., Lee, S., Kim, S. J., Kim, T., & Lee, Y. J. (2025). MXene/PEDOT:PSS-based dual-biomarker impedimetric immunosensor for accurate differentiation of prostate cancer from BPH through urinary detection. Biosensors and Bioelectronics, 289, 117888. https://doi.org/10.1016/j.bios.2025.117888

Vancouver

Feng S, Khan R, Lee S, Kim SJ, Kim T, Lee YJ. MXene/PEDOT:PSS-based dual-biomarker impedimetric immunosensor for accurate differentiation of prostate cancer from BPH through urinary detection. Biosensors and Bioelectronics. 2025;289:117888. doi:10.1016/j.bios.2025.117888

BibTeX
@article{Feng2025,
  author = {Feng, Song and Khan, Rashid and Lee, Seongeun and Kim, Seon Joon and Kim, Taesung and Lee, Yi Jae},
  title = {MXene/PEDOT:PSS-based dual-biomarker impedimetric immunosensor for accurate differentiation of prostate cancer from BPH through urinary detection},
  journal = {Biosensors and Bioelectronics},
  year = {2025},
  volume = {289},
  pages = {117888},
  doi = {10.1016/j.bios.2025.117888}
}
Kostenlos starten →